0.0640
+0.0016
+(2.56%)
At close: April 16 at 1:09:35 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
32,561
32,561
757
-85,936.0470
-72,561.1450
Investing Cash Flow
-19,835
-19,835
-7,609
-4,854.4780
-4,595.8150
Financing Cash Flow
-9,863
-9,863
7,600
40,713.1410
99,339.2580
End Cash Position
10,513
10,513
7,652
6,906.5260
56,983.9100
Capital Expenditure
--
--
-7,609.2530
-4,854.4780
-4,595.8150
Issuance of Capital Stock
35,745
35,745
3,080
--
89,018.1920
Free Cash Flow
32,561
32,561
757
-90,790.5250
-77,156.9600
12/31/2021 - 6/1/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ELIC.ST Elicera Therapeutics AB (publ)
3.2700
-2.39%
FLUI.ST Fluicell AB (publ)
11.64
-2.18%
SYNACT.ST SynAct Pharma AB
18.90
+1.83%
SANION.ST Saniona AB (publ)
6.40
+4.07%
ONCO.ST Oncopeptides AB (publ)
1.9820
+0.51%
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
18.98
-2.16%
GNLX Genelux Corporation
2.6300
+2.33%
AVTE Aerovate Therapeutics, Inc.
2.7500
+2.61%
AVTX Avalo Therapeutics, Inc.
4.4100
-4.75%
DBVT DBV Technologies S.A.
7.98
+0.88%